These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 1351412)

  • 1. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
    Brooks AM; Gillies WE
    Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
    Frishman WH; Fuksbrumer MS; Tannenbaum M
    J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical ophthalmic beta blockers: a comparative review.
    Zimmerman TJ
    J Ocul Pharmacol; 1993; 9(4):373-84. PubMed ID: 7906296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the ocular beta-blockers.
    Sorensen SJ; Abel SR
    Ann Pharmacother; 1996 Jan; 30(1):43-54. PubMed ID: 8773166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of beta-blockers on ocular blood flow in patients with primary open angle glaucoma: a color Doppler imaging study.
    Altan-Yaycioglu R; Türker G; Akdöl S; Acunaş G; Izgi B
    Eur J Ophthalmol; 2001; 11(1):37-46. PubMed ID: 11284483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of 0.5% timolol maleate, 2% carteolol hydrochloride, and 0.3% metipranolol on intraocular pressure and perimetry findings and evaluation of their ocular and systemic effects.
    Mirza GE; Karaküçük S; Temel E
    J Glaucoma; 2000 Feb; 9(1):45-50. PubMed ID: 10708231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
    Phan TM; Nguyen KP; Giacomini JC; Lee DA
    J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.
    Frishman WH; Kowalski M; Nagnur S; Warshafsky S; Sica D
    Heart Dis; 2001; 3(6):386-97. PubMed ID: 11975823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
    Watson PG; Barnett MF; Parker V; Haybittle J
    Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there any benefits of Betoptic S (betaxolol HCl ophthalmic suspension) over other beta-blockers in the treatment of glaucoma?
    Yarangümeli A; Kural G
    Expert Opin Pharmacother; 2004 May; 5(5):1071-81. PubMed ID: 15155109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension.
    Henness S; Swainston Harrison T; Keating GM
    Drugs Aging; 2007; 24(6):509-28. PubMed ID: 17571916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocker eye drops.
    Nurs Times; 2006 May 30-Jun 5; 102(22):29. PubMed ID: 16764382
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
    Diggory P; Cassels-Brown A; Fernandez C
    Age Ageing; 1996 Nov; 25(6):424-8. PubMed ID: 9003876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial and cardiovascular effects of ocular topical B-antagonists in asthmatic subjects: comparison of timolol, carteolol, and metipranolol.
    Le Jeunne CL; Hugues FC; Dufier JL; Munera Y; Bringer L
    J Clin Pharmacol; 1989 Feb; 29(2):97-101. PubMed ID: 2565918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta adrenergic blocking agents for open-angle glaucoma.
    Lee ME
    J Am Optom Assoc; 1988 Jul; 59(7):567-71. PubMed ID: 2900260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Combination Glaucoma Therapies on β-Blocker Exposure.
    Xu K; Campbell EL; Gill SS; Nesdole R; Campbell RJ
    J Glaucoma; 2017 Feb; 26(2):e107-e109. PubMed ID: 28059862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
    Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
    Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension.
    Buckley MM; Goa KL; Clissold SP
    Drugs; 1990 Jul; 40(1):75-90. PubMed ID: 2202584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.